Fresenius appoints CEOMichael Sen, who succeeds Stephan Sturm as CEO of Fresenius, will continue to serve as CEO of Fresenius Kabi until a successor is decided for this position. Lupin receives FDA OK for generic BanzelGeneric Banzel is a prescription add-on medication approved for the treatment of seizures associated with Lennox-Gastaut syndrome in pediatric patients 1 year of age and older and in adults. Intercept reaches agreement with Dr. Reddy’s on generic Ocaliva Intercept has granted Dr. Reddy’s a nonexclusive, royalty-free license to commercialize its generic version of Ocaliva in the United States. Samsung Bioepis, Organon obtain FDA nod for Humira biosimilar Organon is expected to launch Hadlima on or after July 1, 2023. Alembic launches generic Solaraze Generic Solaraze is a nonsteroidal anti-inflammatory drug indicated for the topical treatment of actinic keratoses. ANI obtains FDA OK for generic Decadron Dexamethasone is a type of corticosteroid used to treat several health conditions, including skin conditions, allergies, swelling and autoimmune conditions. Amphastar obtains FDA blessing for epinephrine pre-filled syringes Epinephrine injection is indicated to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock. Alembic launches generic Doryx Generic Doryx should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. 2022 NACDS Total Store Expo product showcase DSN has compiled a non-comprehensive list of companies and some of the new products on offer at this year’s NACDS TSE event. Amneal launches 4 generics Amneal’s generic Vasostrict, which is among the four new product introductions, expands the company’s injectables portfolio. First Previous 86 87 88 89 90 Next Last
